Tuesday, January 03, 2017 2:24:19 PM
380 S. Melrose Dr., Ste. 341, Vista, CA 92081*Office: 800-618-7214*
760-806-4344*Email:aslotaylor@gmail.com
Get Real USA, Inc. Executive Announcement:
GTRL GAINS INSTITUTIONAL INVESTORS WITH VERY BRIGHT FUTURE
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT WITH GPL VENTURES.
Securities Purchase Agreement with GPL Ventures, LLC Kicks Off 2017 in a Big Way
VISTA, CA – (January 3, 2017) Get Real USA, Inc. (GTRL) is pleased to announce they have met all necessary provisions for its $5 million dollar funding commitment from GPL Ventures, LLC.
On December 23, 2016, Get Real USA, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with GPL Ventures, LLC (“GPL”). Pursuant to the Securities Purchase Agreement, the Company, at its sole and exclusive option, may issue and sell to GPL, from time to time as provided therein, and GPL would purchase from the Company shares of the Company’s common stock (“Shares”) equal to a value of up to Five Million Dollars ($5,000,000). The Company will be registering the shares under Regulation A.
“This represents a major milestone in our growth and sets us on a clear path for the future”, said CEO, Aslo Taylor. “We are very pleased to announce that we have met all of the provisions necessary for us to move forward with our $5 million funding commitment. This equity line will now afford us the ability to control our destiny by raising capital at our discretion without taking on additional debt”, he said.
“Additionally, this credit line is structured to produce a more advantageous cost base allowing investors more support and stability. We plan on using a portion of this equity line to eventually eliminate all of our convertible debt in order to create greater shareholder value. We will now be focusing our efforts with strategic marketing in order to build brand awareness for GTRL and Vast Technologies, our digital marketing and web site and mobile app building division.”
For additional information contact:
Trisha Souza, (760) 806-4344
OTC: GTRL
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM